Energy metabolism dysfunction and therapeutic strategies for treating temporomandibular disorders
- PMID: 40641978
- PMCID: PMC12240951
- DOI: 10.3389/fmed.2025.1581446
Energy metabolism dysfunction and therapeutic strategies for treating temporomandibular disorders
Abstract
Temporomandibular disorders (TMD) are prevalent and multifactorial conditions affecting the temporomandibular joint (TMJ). Recent studies have highlighted the central role of energy metabolism in their pathogenesis. This review focuses on how disturbances in glucose, lipid, and mitochondrial energy pathways contribute to TMJ dysfunction and degeneration. The TMJ's complex structure relies heavily on a balanced energy supply to maintain its physiological functions. Disruptions in glucose metabolism lead to oxidative stress, inflammatory cytokine release, and chondrocyte damage. Similarly, altered lipid metabolism-particularly imbalances in ω-3 and ω-6 fatty acids-modifies inflammatory responses. Hormonal influences, including cholesterol and estrogen, further exacerbate joint degeneration via signaling pathways such as Notch and NF-κB. These metabolic disturbances trigger cellular senescence, impaired matrix synthesis, and structural breakdown of cartilage and bone. The review also evaluates current and emerging therapeutic strategies. Standard treatments such as NSAIDs and corticosteroids relieve symptoms but fail to address underlying metabolic dysfunctions. Promising alternatives include intra-articular growth factors, metabolic modulators targeting oxidative stress, and autophagy inducers that restore mitochondrial balance. These approaches aim to correct cellular energy imbalances and support tissue regeneration. TMD involve significant metabolic dysregulation in the TMJ. Understanding the role of energy metabolism offers new insights into disease mechanisms and potential therapies. Future research should prioritize metabolic regulation as a target for long-term and disease-modifying treatments in TMD management.
Keywords: energy metabolism; metabolic dysregulation; temporomandibular disorders; temporomandibular joint; therapeutic strategies.
Copyright © 2025 Gao, Gao, Xiao, Qian, Fan, Li, Yang, Yang and Qiao.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures





Similar articles
-
Orthodontics for treating temporomandibular joint (TMJ) disorders.Cochrane Database Syst Rev. 2010 Jul 7;(7):CD006541. doi: 10.1002/14651858.CD006541.pub2. Cochrane Database Syst Rev. 2010. Update in: Cochrane Database Syst Rev. 2016 Jan 07;(1):CD006541. doi: 10.1002/14651858.CD006541.pub3. PMID: 20614447 Updated.
-
Occlusal interventions for managing temporomandibular disorders.Cochrane Database Syst Rev. 2024 Sep 16;9(9):CD012850. doi: 10.1002/14651858.CD012850.pub2. Cochrane Database Syst Rev. 2024. PMID: 39282765
-
Mitochondrial dynamics dysfunction and neurodevelopmental disorders: From pathological mechanisms to clinical translation.Neural Regen Res. 2025 Jun 19. doi: 10.4103/NRR.NRR-D-24-01422. Online ahead of print. Neural Regen Res. 2025. PMID: 40537021
-
Short-Term Memory Impairment.2024 Jun 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Jun 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 31424720 Free Books & Documents.
-
The Black Book of Psychotropic Dosing and Monitoring.Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. Psychopharmacol Bull. 2024. PMID: 38993656 Free PMC article. Review.
References
-
- McIlwraith C. (2001) Disease processes of synovial membrane, fibrous capsule, ligaments, and articular cartilage. Proceedings of the annual convention – American Association of Equine Practitioners
Publication types
LinkOut - more resources
Full Text Sources